Clinical and Vaccine Trials for COVID-19: Key Considerations from Social Science

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-10-26

Type Web Page Author R. Burns Author L. Enria Author A. Bowmer Author S. Vanderslott Author S. Lees URL https://www.socialscienceinaction.org/resources/clinical-and-vaccine-trials-for-covid-19-key-considerations-from-social-science/ Date 00/00/2020 Website Type Briefings Language en-GB Abstract Previous months have witnessed a growth of clinical research in response to the COVID19 crisis. This brief sets out social science considerations that can inform clinical and vaccine trials for COVID-19. It was developed for SSHAP by London School of Hygiene and Tropical Medicine (LSHTM) by Rose Burns, Alex Bowmer, Luisa Enria, Samantha Vanderslott (University of Oxford) and Shelley Lees in order to inform design, recruitment and community engagement, implementation and results dissemination for trials of emerging vaccine and therapeutic candidates for COVID-19. Colleagues from Dalhousie University and Kings College London reviewed it. The brief is the responsibility of the Social Science in Humanitarian Action Platform. Website Title Social Science in Humanitarian Action Platform Short Title Clinical and Vaccine Trials for COVID-19